With better access to tools like CCTA and diagnostic tools that leverage CCTA, clinicians can better support their patients in managing overall cardiovascular health, patients will benefit from less invasive care and enhanced quality of life, and health systems could ultimately see reduced costs and streamlined workflows.
Highly preventable if diagnosed and managed early, CAD should be a healthcare priority. Both patients and providers have pivotal roles in driving this change.
Medical billing is a tedious administrative task, but outsourcing it may be the key to increased revenue. Explore the top medical billing outsourcing companies and the benefits of partnering with one.
While fibrates are proven to lower triglyceride levels, which can serve as a biomarker for cardiovascular disease risk, several major clinical studies from the past 20 years have failed to show a benefit of fenofibrates over and above statins in further reducing heart-related events.
The mortality rates at rural hospitals for certain conditions, including heart attacks and stroke, decreased in the years following a merger or an acquisition compared with facilities that remained independent, a new study shows. This is a departure from research done on the effects of M&A on urban hospitals.
Not to be a total buzzkill after a joyous day of sharing thanks and gratitude, but it’s true that the mortality rate in the U.S. spikes on Thanksgiving day and remains higher through the end of the year. Part of the reasoning behind this comes from extreme weather and flu season, but part of it […]
In high concentrations, hydrogen sulfide is highly poisonous. But in the small amounts naturally produced by the body, researchers have found that it actually provides many benefits to humans. “Through our work and the work of others, we know that hydrogen sulfide therapy is very effective at preventing and treating cardiovascular disease in a variety […]
Break down the silos. Take control of your provider data.
Reducing the side effects and improving compliance in the millions of people who take aspirin regularly is the goal of a pharmaceutical company raising up to $7.7 million in anticipation of a 2013 NDA filing.
Imagine a man with a recent severe heart attack who has the muscle repaired with stem cells or a child with a severe bladder defect repaired with stem cells grown on a biodegradable scaffold. Sounds like science fiction but these are actual clinical studies in progress today. Stem cell therapies promise to be one of […]